司美格鲁肽致药品不良反应文献分析

R969.3%R977.1+5; 目的 探讨司美格鲁肽致药品不良反应(ADR)的特点,为其临床安全应用提供参考.方法 以"司美格鲁肽""不良反应"等的中英文为检索词,检索PubMed、Web of Science、SpringerLink、中国知网、中华医学期刊全文数据库、万方医学网及维普医药信息资源系统,收集司美格鲁肽致ADR的病例报道并进行分析.结果 共纳入14篇文献,共计17例患者.17例患者中,女性9例、男性8例,年龄25~80岁;8例患者合并应用2种及2种以上药物;8例患者以0.25 mg为起始剂量;大多ADR(94.12%)发生在用药后6个月...

Full description

Saved in:
Bibliographic Details
Published in中国药房 Vol. 35; no. 18; pp. 2266 - 2271
Main Authors 孙如男, 仓代晓, 全香花, 张传洲, 赵俊
Format Journal Article
LanguageChinese
Published 潍坊市妇幼保健院药学部,山东潍坊 261000%青岛大学附属医院药学部,山东青岛 266003 01.09.2024
青岛大学附属医院药学部,山东青岛 266003
临沭县中医医院药剂科,山东临沂 276700%青岛大学附属医院药学部,山东青岛 266003
Subjects
Online AccessGet full text
ISSN1001-0408
DOI10.6039/j.issn.1001-0408.2024.18.13

Cover

Abstract R969.3%R977.1+5; 目的 探讨司美格鲁肽致药品不良反应(ADR)的特点,为其临床安全应用提供参考.方法 以"司美格鲁肽""不良反应"等的中英文为检索词,检索PubMed、Web of Science、SpringerLink、中国知网、中华医学期刊全文数据库、万方医学网及维普医药信息资源系统,收集司美格鲁肽致ADR的病例报道并进行分析.结果 共纳入14篇文献,共计17例患者.17例患者中,女性9例、男性8例,年龄25~80岁;8例患者合并应用2种及2种以上药物;8例患者以0.25 mg为起始剂量;大多ADR(94.12%)发生在用药后6个月内;16例患者经停药和/或对症治疗后均好转或痊愈;11例患者未提及后续是否继续使用司美格鲁肽;9例患者进行了ADR相关性评价,断定为"肯定""很可能""可能""有可能"的分别有1、3、1、4例.司美格鲁肽致ADR可累及多个器官或系统,以消化系统最多(35.29%),其次为皮肤组织(29.41%);其中,急性胃扩张、重度肝损伤、结石性胆囊炎、大疱性类天疱疮、嗜酸性筋膜炎、急性肾损伤、急性间质性肾炎、抑郁症、急性溶血性贫血均为药品说明书未记载的ADR.结论 司美格鲁肽所致ADR可发生在各年龄段,以用药后6个月内发生为主,主要累及消化系统、皮肤组织等.临床使用时,应重点加强对肝肾功能不全、神经精神疾病、葡萄糖-6-磷酸脱氢酶缺乏症等人群的药学监护,出现相关ADR时应及时停药和/或对症治疗,以保障患者的用药安全.
AbstractList R969.3%R977.1+5; 目的 探讨司美格鲁肽致药品不良反应(ADR)的特点,为其临床安全应用提供参考.方法 以"司美格鲁肽""不良反应"等的中英文为检索词,检索PubMed、Web of Science、SpringerLink、中国知网、中华医学期刊全文数据库、万方医学网及维普医药信息资源系统,收集司美格鲁肽致ADR的病例报道并进行分析.结果 共纳入14篇文献,共计17例患者.17例患者中,女性9例、男性8例,年龄25~80岁;8例患者合并应用2种及2种以上药物;8例患者以0.25 mg为起始剂量;大多ADR(94.12%)发生在用药后6个月内;16例患者经停药和/或对症治疗后均好转或痊愈;11例患者未提及后续是否继续使用司美格鲁肽;9例患者进行了ADR相关性评价,断定为"肯定""很可能""可能""有可能"的分别有1、3、1、4例.司美格鲁肽致ADR可累及多个器官或系统,以消化系统最多(35.29%),其次为皮肤组织(29.41%);其中,急性胃扩张、重度肝损伤、结石性胆囊炎、大疱性类天疱疮、嗜酸性筋膜炎、急性肾损伤、急性间质性肾炎、抑郁症、急性溶血性贫血均为药品说明书未记载的ADR.结论 司美格鲁肽所致ADR可发生在各年龄段,以用药后6个月内发生为主,主要累及消化系统、皮肤组织等.临床使用时,应重点加强对肝肾功能不全、神经精神疾病、葡萄糖-6-磷酸脱氢酶缺乏症等人群的药学监护,出现相关ADR时应及时停药和/或对症治疗,以保障患者的用药安全.
Abstract_FL OBJECTIVE To explore the characteristics of adverse drug reaction(ADR)induced by semaglutide and provide a reference for clinically safe medication.METHODS Using search terms such as"semaglutide"and"adverse reactions"in both Chinese and English,the case reports about ADRs caused by semaglutide were searched and analyzed from PubMed,Web of Science,SpringerLink,CNKI,Chinese Medical Journal Full-text Database,Wanfang Medical Network and VMIS.RESULTS Overall 14 literature were included,involving 17 patients.Among 17 patients,9 were female and 8 were male,with the age ranging from 25 to 80 years.Eight patients were given two or more drugs,and eight patients took 0.25 mg as the initial dose;the ADR occurred most frequently within 6 months(94.12%).Sixteen patients'symptoms improved or recovered after drug withdrawal and symptomatic treatment.Eleven patients did not mention whether to continue to use semaglutide in the future.Nine patients underwent ADR correlation evaluation,and 1,3,1 and 4 cases were determined to be"definite","probable","possible",and"doubtful"respectively.Semaglutide-induced ADRs involved multiple organs or systems,most of which were the digestive system(35.29%),followed by skin tissue(29.41%).Among them,acute gastric dilation,severe liver injury,calculous cholecystitis,bullous pemphigoid,eosinophilic fasciitis,acute kidney injury,acute interstitial nephritis,depression and acute hemolytic anemia were not mentioned in the instruction.CONCLUSIONS ADRs caused by semaglutide can occur in all ages,mainly within 6 months after medication,and mainly involve the digestive system,skin tissue,etc.Great attention should be paid to pharmaceutical care for those patients with liver and kidney dysfunction,neuropsychiatric diseases,glucose-6-phosphate dehydrogenase deficiency,etc.When ADR occurs,drug withdrawal and symptomatic treatment should be performed promptly to ensure patients'medication safety.
Author 仓代晓
全香花
赵俊
孙如男
张传洲
AuthorAffiliation 青岛大学附属医院药学部,山东青岛 266003;潍坊市妇幼保健院药学部,山东潍坊 261000%青岛大学附属医院药学部,山东青岛 266003;临沭县中医医院药剂科,山东临沂 276700%青岛大学附属医院药学部,山东青岛 266003
AuthorAffiliation_xml – name: 青岛大学附属医院药学部,山东青岛 266003;潍坊市妇幼保健院药学部,山东潍坊 261000%青岛大学附属医院药学部,山东青岛 266003;临沭县中医医院药剂科,山东临沂 276700%青岛大学附属医院药学部,山东青岛 266003
Author_FL QUAN Xianghua
ZHAO Jun
ZHANG Chuanzhou
SUN Runan
CANG Daixiao
Author_FL_xml – sequence: 1
  fullname: SUN Runan
– sequence: 2
  fullname: CANG Daixiao
– sequence: 3
  fullname: QUAN Xianghua
– sequence: 4
  fullname: ZHANG Chuanzhou
– sequence: 5
  fullname: ZHAO Jun
Author_xml – sequence: 1
  fullname: 孙如男
– sequence: 2
  fullname: 仓代晓
– sequence: 3
  fullname: 全香花
– sequence: 4
  fullname: 张传洲
– sequence: 5
  fullname: 赵俊
BookMark eNo9j81KAzEURrOoYFt9CnE58d4kk0mWUvyDghtdl8xkUhxkCgYR3dWFVbC2oLgUn8CCuCiiPo0zHd_CiuLqg7M4h69BankvTwlZQaASuF7L6IH3OUUADECAogyYoKgo8hqp_-NF0vA-AxCoJdYJFKPp7OOmfHz7eu5X5-_V4KUaTorb_ud0WF1NitGweL0r7wez66fi8qJ8GC-RBWcOfbr8t02yv7mx19oO2rtbO631duDnKR5og0wrSFRsdByGoUzQGqtYgkKic0liubUCnNCpgogpjOKQRVxaLSMldMybZPXXe2JyZ_JuJ-sdH-XzYuese-p-vqEC5PwbPLJYGQ
ClassificationCodes R969.3%R977.1+5
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2B.
4A8
92I
93N
PSX
TCJ
DOI 10.6039/j.issn.1001-0408.2024.18.13
DatabaseName Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitle_FL Literature analysis of semaglutide-induced adverse drug reaction
EndPage 2271
ExternalDocumentID zgyf202418013
GrantInformation_xml – fundername: 山东省自然科学基金青年项目
  funderid: (No.ZR2021QH205)
GroupedDBID -05
2B.
4A8
5GY
5XA
5XF
92F
92I
93N
ABJNI
ACGFS
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CIEJG
CW9
GROUPED_DOAJ
PSX
TCJ
TGQ
U1G
U5O
ID FETCH-LOGICAL-s1003-9a12980c8ba9b5556c1dad82c1461ffccd3dd40f49e8072817b52736d967849b3
ISSN 1001-0408
IngestDate Thu May 29 04:00:04 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 18
Keywords 文献分析
literature analysis
病例报道
adverse drug reaction
不良反应
case report
司美格鲁肽
semaglutide
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-s1003-9a12980c8ba9b5556c1dad82c1461ffccd3dd40f49e8072817b52736d967849b3
PageCount 6
ParticipantIDs wanfang_journals_zgyf202418013
PublicationCentury 2000
PublicationDate 2024-09-01
PublicationDateYYYYMMDD 2024-09-01
PublicationDate_xml – month: 09
  year: 2024
  text: 2024-09-01
  day: 01
PublicationDecade 2020
PublicationTitle 中国药房
PublicationTitle_FL China Pharmacy
PublicationYear 2024
Publisher 潍坊市妇幼保健院药学部,山东潍坊 261000%青岛大学附属医院药学部,山东青岛 266003
青岛大学附属医院药学部,山东青岛 266003
临沭县中医医院药剂科,山东临沂 276700%青岛大学附属医院药学部,山东青岛 266003
Publisher_xml – name: 潍坊市妇幼保健院药学部,山东潍坊 261000%青岛大学附属医院药学部,山东青岛 266003
– name: 临沭县中医医院药剂科,山东临沂 276700%青岛大学附属医院药学部,山东青岛 266003
– name: 青岛大学附属医院药学部,山东青岛 266003
SSID ssj0041961
ssib051369179
ssib001103784
ssib017477153
Score 2.3648522
Snippet R969.3%R977.1+5; 目的 探讨司美格鲁肽致药品不良反应(ADR)的特点,为其临床安全应用提供参考.方法 以"司美格鲁肽""不良反应"等的中英文为检索词,检索PubMed、Web of...
SourceID wanfang
SourceType Aggregation Database
StartPage 2266
Title 司美格鲁肽致药品不良反应文献分析
URI https://d.wanfangdata.com.cn/periodical/zgyf202418013
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxRBEG6SCOJFfOIzLGjnYnad6dd0H2d2ZwmCkkMCuYV57CSnFdzkkNziwSgYIygexV9gQDwEUX-Nm6y_Qqu6Z3cnUXwElqG3--uvaqt2pmuarm5CbudJJnXOeV3KlNdF3tHwHExZHbceESmEyMouHr__QM0tintLcmli8kdl1dL6WtrINn-bV3ISr0Id-BWzZP_DsyNSqIAy-Beu4GG4_pOPaSypbtNI0zigUUx1TGNFQ49GTRobGjGIE2msqWY0atkCwIQttGjYxu6GW4xAEu0wpmwCZqyRNAqpEchsFDKALN2kYWwxgFe2KabuQM5hpFtyhpbBREMFnFyFHaPRomKEANAYW1CoLwgBmVEwhsC3CNV1hZBbqYYaXmXR0F_jbw9tI0oMaeRXIWAbsBCyuIJCk0SsOv3BxGh9l_vDWlSrNIdpISkyWcuWKge2xljTA18bYaiQT0OJCoE2ITtievjF0BGaNEelWdMy-PhxtjPNX-XegXdRD0_WdqRgNKsBuBpsjKSChsERdhCsRUltnNOaaMGT63RcLugEAS2vjG92BZ3wdHUAdPvFDG90XR3OmFKV0Igxd1zO8WFXedzYYRdlNEYyGuivhq8bLtv42L7mmysbBQJ8iJH4JDnFgsCtsyjnRGw8j1ms40RqeHsG0Di-lD5Xxp6g50IvAcOJnWEZanCa3CrVu_sH5Wy-XrdIuiuV0HLhHDlbvhPWQneDnycTm6sXyMy821R-Y7a2MM6R7M3WZmrz4-3mNy4Sr7-7f_j1xcG7z98_bA0efxlsfxzs7PVfbX3b3xk82-vv7vQ_vT54s334_H3_6ZODty8vkcV2vNCcq5fnoNR7Pi4dNQkE5drLdJqYVEqpMj9Pcs0yiHL8osiynOe58AphOtoLmPaDFLdVVLmBSFSYlF8mU92H3c4VUit0gZn4iZd7OJGSJTJPOqzQWaaNybm8SqZLUyyXz7ne8hFHXfsb4Do5M75Nb5CptUfrnZsQt6-l09a3PwHr3qek
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%8F%B8%E7%BE%8E%E6%A0%BC%E9%B2%81%E8%82%BD%E8%87%B4%E8%8D%AF%E5%93%81%E4%B8%8D%E8%89%AF%E5%8F%8D%E5%BA%94%E6%96%87%E7%8C%AE%E5%88%86%E6%9E%90&rft.jtitle=%E4%B8%AD%E5%9B%BD%E8%8D%AF%E6%88%BF&rft.au=%E5%AD%99%E5%A6%82%E7%94%B7&rft.au=%E4%BB%93%E4%BB%A3%E6%99%93&rft.au=%E5%85%A8%E9%A6%99%E8%8A%B1&rft.au=%E5%BC%A0%E4%BC%A0%E6%B4%B2&rft.date=2024-09-01&rft.pub=%E6%BD%8D%E5%9D%8A%E5%B8%82%E5%A6%87%E5%B9%BC%E4%BF%9D%E5%81%A5%E9%99%A2%E8%8D%AF%E5%AD%A6%E9%83%A8%2C%E5%B1%B1%E4%B8%9C%E6%BD%8D%E5%9D%8A+261000%25%E9%9D%92%E5%B2%9B%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E5%8C%BB%E9%99%A2%E8%8D%AF%E5%AD%A6%E9%83%A8%2C%E5%B1%B1%E4%B8%9C%E9%9D%92%E5%B2%9B+266003&rft.issn=1001-0408&rft.volume=35&rft.issue=18&rft.spage=2266&rft.epage=2271&rft_id=info:doi/10.6039%2Fj.issn.1001-0408.2024.18.13&rft.externalDocID=zgyf202418013
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgyf%2Fzgyf.jpg